זולפידם
הערות שוליים

1 2 3 4 5 6 7  Zolpidem Monograph for Professionals, Drugs.com (באנגלית)
1 2  1 Guidance | Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | Guidance | NICE, www.nice.org.uk, ‏2004-04-28
1 2  Dieter Riemann, Chiara Baglioni, Claudio Bassetti, Bjørn Bjorvatn, Leja Dolenc Groselj, Jason G. Ellis, Colin A. Espie, Diego Garcia‐Borreguero, Michaela Gjerstad, Marta Gonçalves, Elisabeth Hertenstein, Markus Jansson‐Fröjmark, Poul J. Jennum, Damien Leger, Christoph Nissen, Liborio Parrino, Tiina Paunio, Dirk Pevernagie, Johan Verbraecken, Hans‐Günter Weeß, Adam Wichniak, Irina Zavalko, Erna S. Arnardottir, Oana‐Claudia Deleanu, Barbara Strazisar, Marielle Zoetmulder, Kai Spiegelhalder, European guideline for the diagnosis and treatment of insomnia, Journal of Sleep Research 26, 2017-12, עמ' 675–700 doi: 10.1111/jsr.12594
1 2  Amir Qaseem, Devan Kansagara, Mary Ann Forciea, Molly Cooke, Thomas D. Denberg, for the Clinical Guidelines Committee of the American College of Physicians, Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians, Annals of Internal Medicine 165, 2016-07-19, עמ' 125 doi: 10.7326/M15-2175
1 2 3  Eric Matheson, Barry L. Hainer, Insomnia: Pharmacologic Therapy, American Family Physician 96, 2017-07-01, עמ' 29–35
1 2  Naren Gunja, The Clinical and Forensic Toxicology of Z-drugs, Journal of Medical Toxicology 9, 2013-6, עמ' 155–162 doi: 10.1007/s13181-013-0292-0
↑  Tania B Huedo-Medina, Irving Kirsch, Jo Middlemass, Markos Klonizakis, A Niroshan Siriwardena, Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration, The BMJ 345, 2012-12-17, עמ' e8343 doi: 10.1136/bmj.e8343
1 2 3 4 5 6  Stilnoct 10mg Film-Coated Tablets - Summary of Product Characteristics (SmPC) - (eMC), web.archive.org, ‏2018-08-20
↑  FDA requires lower dosing of zolpidem, The Medical Letter on Drugs and Therapeutics 55, 2013-01-21, עמ' 5
↑  FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist), web.archive.org, ‏2017-07-22
↑  Susan E. Merel, Douglas S. Paauw, Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care, Journal of the American Geriatrics Society 65, 2017-07, עמ' 1578–1585 doi: 10.1111/jgs.14870
↑  By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel, American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, Journal of the American Geriatrics Society 63, 2015-11, עמ' 2227–2246 doi: 10.1111/jgs.13702
1 2 3 4  Pregnancy, breastfeeding and fertility while taking zolpidem, nhs.uk, ‏2023-01-12 (באנגלית)
↑  DailyMed - AMBIEN- zolpidem tartrate tablet, film coated, dailymed.nlm.nih.gov
↑  Daniel F. Kripke, Mortality Risk of Hypnotics: Strengths and Limits of Evidence, Drug Safety 39, 2016-02, עמ' 93–107 doi: 10.1007/s40264-015-0362-0
↑  Annemiek Vermeeren, Residual Effects of Hypnotics, CNS Drugs 18, 2004-04-01, עמ' 297–328 doi: 10.2165/00023210-200418050-00003
↑  S. M. Park, J. Ryu, D. R. Lee, D. Shin, J. M. Yun, J. Lee, Zolpidem use and risk of fractures: a systematic review and meta-analysis, Osteoporosis International 27, 2016-10-01, עמ' 2935–2944 doi: 10.1007/s00198-016-3605-8
↑  Naren Gunja, The Clinical and Forensic Toxicology of Z-drugs, Journal of Medical Toxicology 9, 2013-6, עמ' 155–162 doi: 10.1007/s13181-013-0292-0
↑  Naren Gunja, In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving, Journal of Medical Toxicology 9, 2013-6, עמ' 163–171 doi: 10.1007/s13181-013-0294-y
1 2 3  Katrin Janhsen, Patrik Roser, Knut Hoffmann, The Problems of Long-Term Treatment With Benzodiazepines and Related Substances, Deutsches Ärzteblatt International 112, 2015-1, עמ' 1–7 doi: 10.3238/arztebl.2015.0001
↑  Caroline Victorri-Vigneau, Marie Gérardin, Morgane Rousselet, Marylène Guerlais, Marie Grall-Bronnec, Pascale Jolliet, An Update on Zolpidem Abuse and Dependence, Journal of Addictive Diseases 33, 2014-01, עמ' 15–23 doi: 10.1080/10550887.2014.882725
1 2 3 4 5  Pau Salvà, Joan Costa, Clinical Pharmacokinetics and Pharmacodynamics of Zolpidem, Clinical Pharmacokinetics 29, 1995-09-01, עמ' 142–153 doi: 10.2165/00003088-199529030-00002
↑  Ahmad Tarmizi Che Has, Nathan Absalom, Petra S. van Nieuwenhuijzen, Andrew N. Clarkson, Philip K. Ahring, Mary Chebib, Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface, Scientific Reports 6, 2016-06-27, עמ' 28674 doi: 10.1038/srep28674
↑  Dolan B. Pritchett, Peter H. Seeburg, γ‐Aminobutyric Acid A Receptor α 5 ‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology, Journal of Neurochemistry 54, 1990-05, עמ' 1802–1804 doi: 10.1111/j.1471-4159.1990.tb01237.x
↑  Alison J. Smith, Luanda Alder, Jonathan Silk, Charles Adkins, Alan E. Fletcher, Tim Scales, Julie Kerby, George Marshall, Keith A. Wafford, Ruth M. McKernan, John R. Atack, Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidA Receptors Determined Using36Cl Ion Flux, Molecular Pharmacology 59, 2001-05-01, עמ' 1108–1118 doi: 10.1124/mol.59.5.1108
↑  James K. Rowlett, W. L. Woolverton, Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies, Psychopharmacology 128, 1996-11-01, עמ' 1–16 doi: 10.1007/s002130050103
↑  Hideaki Noguchi, Kazuhiro Kitazumi, Megumi Mori, Toshiharu Shiba, Electroencephalographic Properties of Zaleplon, a Non-Benzodiazepine Sedative/Hypnotic, in Rats, Journal of Pharmacological Sciences 94, 2004, עמ' 246–251 doi: 10.1254/jphs.94.246
↑  Yenal Dündar, Susanna Dodd, Judith Strobl, Angela Boland, Rumona Dickson, Tom Walley, Comparative efficacy of newer hypnotic drugs for the short‐term management of insomnia: a systematic review and meta‐analysis, Human Psychopharmacology: Clinical and Experimental 19, 2004-07, עמ' 305–322 doi: 10.1002/hup.594
↑  David J. Greenblatt, Jerold S. Harmatz, Thomas Roth, Zolpidem and Gender: Are Women Really At Risk?, Journal of Clinical Psychopharmacology 39, May/June 2019, עמ' 189 doi: 10.1097/JCP.0000000000001026
↑  Center for Drug Evaluation and Research, FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning, FDA, 2019-03-20
↑  Center for Drug Evaluation and Research, FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks, FDA, 2021-01-07